Tenet Healthcare slips despite Q1 EPS beat as one-time CommonSpirit boost dominates
THC•Tenet Healthcare shares fell after first-quarter 2026 results that included a large, non-recurring earnings boost tied to the CommonSpirit/Conifer contract termination, making the headline profit less repeatable. Investors also focused on softer underlying trends, including unfavorable payer mix from lower exchange admissions, even as the company reaffirmed full-year 2026 guidance.
1. What’s moving the stock
Tenet Healthcare (THC) traded lower Thursday after reporting first-quarter 2026 results that featured a sharp jump in GAAP net income, but investors appeared to discount the quality of the beat because a meaningful portion was driven by non-recurring items tied to the recently announced CommonSpirit/Conifer agreement. The company reported net income available to common shareholders of $702 million ($8.01 per diluted share) and adjusted EPS of $4.82, with net operating revenues of $5.368 billion for the quarter ended March 31, 2026. ()
